Endometriosis: 1 in 10 women affected, yet diagnosis lags a decade or more

Every year, millions of women cycle through primary care, gynecology, and emergency departments with endometriosis symptoms — yet the American College of Obstetricians & Gynecologists reports patients can wait a decade or more for a diagnosis. That delay is a clinical workflow and health IT failure as much as a biological one: symptoms present early (Zoë Armstrong's began at age 11), but definitive answers require imaging and tests that are unevenly deployed. For health systems, the promise of non-invasive tests already in use abroad raises a pressing operational question: how quickly can U.S. providers adopt imaging-based screening to close a gap that costs patients years of avoidable pain and lost productivity?

The case of Zoë Armstrong — a 31-year-old who wept with relief when an ultrasound finally showed signs of endometriosis after roughly two decades of unexplained symptoms — puts a human face on one of women's health's most persistent diagnostic failures. The American College of Obstetricians & Gynecologists reports that patients can wait a decade or more after symptom onset before receiving an endometriosis diagnosis, and the condition affects an estimated 1 in 10 women worldwide. Armstrong's first symptoms were stabbing pains on her left side that repeatedly sent her to the school nurse at age 11; as an adult she endured severe pain, nausea, heavy periods, acne, and rupturing ovarian cysts. After marrying, she described pain like having a tiny fencer inside her. An ultrasound report finally gave her an answer: 'To see it on paper, I was like, I'm not crazy.'

“

Every year, millions of women cycle through primary care, gynecology, and emergency departments with endometriosis symptoms — yet the American College of Obstetricians & Gynecologists reports patients can wait a decade or more for a diagnosis.

Clinically, endometriosis is best understood as a chronic inflammatory disease in which tissue similar to the uterine lining grows elsewhere in the body — most commonly the bladder, bowel, or ovaries, and in rare cases outside the pelvis. Its exact cause remains unknown, though genetics is thought to play a part. Symptoms vary with the extent and location of lesions and typically include pain during periods, intercourse, and bowel movements, along with bloating, fatigue, and infertility. Dr. Drorit Or of Mount Sinai West in New York describes the toll in plain terms: 'It can be debilitating pain that makes you not be able to go to school or work or be in bed for days at a time.'

The diagnostic bottleneck sits at the center of the problem. Because symptoms overlap with other conditions and definitive diagnosis has historically depended on invasive surgical visualization, patients often cycle through providers for years before answers emerge. For patients, the result is a diagnostic odyssey measured not in weeks but in decades — less a clinical workflow than a failure of early triage and symptom recognition. The reporting notes that new tests used in other countries are raising hopes among both doctors and patients — but they are not currently available in the United States, and some experts expect them to be a useful tool rather than a complete solution. That caveat is telling: it implies non-invasive imaging or biomarker approaches may accelerate triage while still missing the superficial or atypical disease that a surgeon's eye would catch, keeping laparoscopy relevant for now.